The Clinical Research Team at MAPS conducts rigorous studies to evaluate the safety and efficacy of psychedelics, particularly MDMA, in therapeutic settings. Team members play various roles, from adherence raters to principal investigators, ensuring compliance with trial protocols, collecting data, and providing therapeutic support during treatment sessions. Their work advances scientific understanding of psychedelics, aiming to integrate these substances into mainstream mental health care.
View all